INHIBITING THE HYPOXIC PULMONARY VASOCONSTRICTIVE (HPV) RESPONSE BY UTILIZING PERFLUOROCARBONS AS NOVEL INTRAPULMONARY DRUG DELIVERY AGENTS

The Regents Of The University Of Colorado

Investigators